Study of BMS-587101 in Patients With Moderate to Severe Psoriasis
Clinical trial NCT00162253 · TERMINATED
Trial details
- NCT number
- NCT00162253
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-04-01
- Primary completion
- 2006-06-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.